Doctor profile · Federal record

Dr. Marypat Clements, D.O.

Rheumatology Physician (CMS: Rheumatology) · Delray Beach, FL

  • NPI 1811098569
  • Accepts Medicare
  • MIPS 83.8 / 100 · 2023
  • 34 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
5130 Linton Blvd, Suite F-1
Delray Beach, FL 334846596
(561) 495-0600
fax (561) 495-1301

Credentials & registration

NPPES · NUCC
NPI registered
September 2006 — 20 yrs on file
Profile last updated
February 4, 2014
Year of graduation
1992 — 34 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Florida #OS 7900

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1811098569. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
153,931
Distinct HCPCS
10
Medicare allowed
$2,320,851
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 38,400 28 $5
J0897 Injection, denosumab, 1 mg 28,860 309 $23
J3262 Injection, tocilizumab, 1 mg 25,880 18 $6
J3111 Injection, romosozumab-aqqg, 1 mg 22,890 25 $10
J1602 Injection, golimumab, 1 mg, for intravenous use 7,375 11 $13
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 4,837 334 $1
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 4,700 17 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 4,310 35 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 1,487 631 $132
J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg 1,056 17 $17

In context: peer comparison

Among 9 peers in Delray Beach Rheumatology Physician, average services per provider: 2,434. This provider delivers 63× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,864
Transactions
125
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 24 $515.38
Ucb, INC. 14 $384.01
Novartis Pharmaceuticals Corporation 16 $272.87
Pfizer INC. 18 $248.41
Radius Health, INC. 9 $214.33
Abbvie INC. 7 $163.94
E.R. Squibb & Sons, L.L.C. 7 $160.82
AstraZeneca Pharmaceuticals Lp 6 $115.85
Boehringer Ingelheim Pharmaceuticals, INC. 4 $97.07
Janssen Biotech, INC. 4 $95.14
GlaxoSmithKline, LLC. 5 $93.05
Mallinckrodt Hospital Products INC. 3 $92.26
Sobi, INC 3 $56.10
Scilex Pharmaceuticals INC. 3 $55.37
Biocon Biologics INC 2 $49.43

By nature of payment

Food and Beverage
$2,844
Education
$19

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,939
Patients
693
Total drug cost
$217,832
Drug Type Claims Patients Total cost
Duloxetine Hcl Generic 289 88 $8,352
Tramadol Hcl Generic 265 79 $2,384
Pregabalin Generic 232 56 $5,932
Prednisone Generic 189 57 $1,952
Gabapentin Generic 167 56 $2,403
Hydroxychloroquine Sulfate Generic 126 44 $11,388
Prolia (Denosumab) Brand 105 79 $173,315
Methotrexate (Methotrexate Sodium) Brand 98 32 $3,669
Celecoxib Generic 83 34 $1,936
Meloxicam Generic 82 44 $443

Frequently asked questions

Auto-generated from federal data
What is Dr. Marypat Clements's medical specialty?
Dr. Marypat Clements practices Rheumatology Physician in Delray Beach, FL.
Where does Dr. Marypat Clements practice?
Dr. Marypat Clements practices at 5130 Linton Blvd, Delray Beach, FL 334846596. Office phone: 5614950600.
What is Dr. Marypat Clements's NPI?
Dr. Marypat Clements's National Provider Identifier (NPI) is 1811098569, issued by NPPES.
Does Dr. Marypat Clements accept Medicare assignment?
Yes. Dr. Marypat Clements accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Marypat Clements commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Injection, tocilizumab, 1 mg (HCPCS J3262). Source: CMS Medicare Physician & Other Practitioners file.